Conference Presentation Details - Table of Contents

This activity is part of PER's Integrated Oncology Learning Series: A Focus on Thoracic Malignancies

Sixth Annual Symposium on the Future of Lung Cancer

Release Date: December 13, 2009| Dec 5, 2009, Washington, DC

Table of Contents

Impact of Histology on Response and Patient Selection
Nathan A. Pennell

Debate: Early Second-line Therapy/Maintenance Therapy Is Standard of Care - Pro
H. Jack West

Debate: Early Second-line Therapy/Maintenance Therapy Is Standard of Care - Con
Nasser H. Hanna

Optimizing EGFR Inhibition in Lung Cancer
Lecia V. Sequist

New Indications for Antiangiogenic Agents
David R. Spigel

Multidisciplinary Management of Locoregional NSCLC
Todd Demmy
David S. Ettinger
Quynh-Thu Le

Management of Metastatic NSCLC: Markers, Selection of Therapy, Maintenance Therapy, Supportive Care
Todd Demmy
David S. Ettinger
Quynh-Thu Le

New Systemic Therapies in Locally Advanced NSCLC
Ramaswamy Govindan

Surgery in Locally Advanced NSCLC
Frank C. Detterbeck

Inhibiting EML4-ALK in Lung Cancer
Alice Tsang Shaw

Novel Disruptors of Tumor Vasculature
David R. Spigel

Inhibiting Histone Deacetylases
Suresh Ramalingam

mTOR Inhibitors
Bruce E. Johnson

IGF-1R Inhibitors
Corey Langer

HSP90 Inhibitors
Scott N. Gettinger

Instructions for Participation

To view the streaming Flash Video lectures, click the "Listen to the Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>

To download Podcast-ready movies, click "Download the Presentation," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>

View the Activity
You will be asked to login
or create an account.

Educational Grants

An educational grant for this activity was provided by:


  1. Boehringer Ingelheim Pharmaceuticals, Inc.
  2. Eli Lilly and Company
  3. Genentech BioOncology/
    OSI Oncology
  4. Merck Oncology
  5. Agennix, Inc.
  6. Novartis Oncology